EnvisionRx, a pharmacy benefit manager (PBM) and division of EnvisionRxOptions, a wholly owned subsidiary of Rite Aid Corp., recently announced that URAC renewed the company’s accreditation for pharmacy benefit management.
“Envision was built on a progressive idea that gave plan sponsors real transparency in the management of their pharmacy benefit," Matthew Gibbs, president of commercial and managed markets for EnvisionRx, said in a statement. "Because we provide this level of clarity, Envision has to make sure we run an efficient, effective PBM for both our payer clients and their members. The renewal of our URAC accreditation is proof that Envision continues to integrate new ideas with a focus on quality, and that our approach improves cost and care for patients, as well as health plans, labor groups and employers of all sizes."
EnvisionRx noted that it also has URAC accreditation for drug therapy management. EnvisionPharmacies, another division within EnvisionRxOptions, is accredited by the URAC for mail order pharmacy and specialty pharmacy.
“URAC accreditation shows that EnvisionRx is a pharmacy benefit management organization able to adhere to standards that cover important aspects of care such as claims processing, developing proper drug formulary, and consumer access,” URAC President and CEO Kylanne Green said. “Quality policies and procedures are paramount as the price and complexity of medications rise. EnvisionRx chose to demonstrate their performance through URAC’s independent accreditation of their services.”